Posted by Michael Wonder on 10 Dec 2020
FDA holds advisory committee meeting to discuss authorisation of COVID-19 vaccine candidate as part of Agency’s review of safety and effectiveness data
10 December 2020 - The following is attributed to FDA Commissioner Stephen M. Hahn.
Today, the FDA’s Vaccines and Related Biological Products Advisory Committee, made up of independent scientific and public health experts from around the country, is meeting to discuss the first request for emergency use authorisation for a vaccine for COVID-19 prevention, submitted by Pfizer in partnership with BioNTech.
The FDA recognises that transparency and dialogue are critical to building public confidence in COVID-19 vaccines.
